https://prabadinews.com/
  • October 7, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products

Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products

This draft guidance provides guidance to sponsors and applicants submitting investigational new drug applications (INDs), new drug applications (NDAs), biologics licensing applications (BLAs), or supplemental applications on the appropriate use of Bayesian methods in clinical trials.

administrator

Related Articles